OpenVSafe by OpenVAERS
Search V-safe

7HR-32904-39547

2 vaccinations 2 coded responses 15 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
05-11
ZIP prefix
759 / TX
Registered
2022-01-07
Relationship
Child or adolescent in my care
Guardian
6VW-15784-97217
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-09
    Dose 1 — Pfizer-BioNTech
  2. 2022-01-06
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-07
    Registered in v-safe
  4. 2022-01-07
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain · Joint pains
    Adult check-in
  5. 2022-01-08
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Itching · None
    Adult check-in
  6. 2022-01-09
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Itching · None
    Adult check-in
  7. 2022-01-10
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-01-11
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-01-12
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2022-01-13
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2022-01-20
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2022-01-27
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2022-02-03
    Survey response — day 28, dose 2, dependent
    MedDRA: Paranasal sinus hypersecretion — Feeling: Good
    Free text: Sore throat and sinus drainage, no temp
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-02-10
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  15. 2022-02-17
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  16. 2022-04-07
  17. 2022-07-09
  18. 2023-01-06
    Survey response — 12 months, dose 2, dependent
    MedDRA: Exposure to SARS-CoV-2, Influenza, Medical counselling, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  19. 2023-01-06
    Report sent to call center — 12 months, dose 2, dependent
    Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2023-01-09

Vaccinations

DoseDateManufacturerCo-administered
12021-12-09Pfizer-BioNTech No
22022-01-06Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — day 28, dose 2, dependent

2022-02-03

Symptoms: Sore throat and sinus drainage, no temp

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDInfluenza · · ✓
SDParanasal sinus hypersecretion · · ✓
SDSARS-CoV-2 test negative · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release